Amgen stock edges higher as investors weigh recent revenue growth and obesity drug opportunity

Amgen stock edges higher as investors weigh recent revenue growth and obesity drug opportunity  ad-hoc-news.de

Summary aggregated from ad-hoc-news.de's public RSS feed. The full reporting belongs to ad-hoc-news.de — please read it on their site.